Monday, July 14, 2025 3:00 PM Eastern Time / 12:00 PM Pacific Time
Presenter: Rosa H. Jimenz, M.D., PhD, MG Indication Lead, Clinical Development, argenx
Join Dr. Jimenz for a webinar sharing more information about a clinical study open to adults with ocular myasthenia gravis. This study is assessing the safety and efficacy of efgartigimod PH20 SC (a version of Vyvgart) in treating ocular MG.
Come join us to learn more and ask your questions about participating in a clinical trial.
This webinar is sponsored by argenx.